GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.

$3.98
As of 03/01/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
Israel

03/13/2014
21,113,066
742,677
$84,452,264
0.00%
SEC Edgar Online
20-F
M47238106


Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
1.09
0.00
-49.91%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy